Pinpointing the “end” of the coronavirus pandemic depends on the vantage point. The World’s host Marco Werman spoke with Dr. Michael Mina, a leading epidemiologist and the chief science officer at EMed, a digital health care company, along with Zeynep Tufekci, a sociologist and professor at Columbia University, to learn more about the “bumpy, difficult off-ramp” from COVID-19.
Scientists around the world are researching the potential of antibodies to fight the coronavirus pandemic. As part of our weekly discussion series taking your questions to the experts, The World’s Jonathan Dyer moderated a conversation with epidemiologist Michael Mina of Harvard’s T.H. Chan School of Public Health.
Despite efforts to ramp up testing for COVID-19, gaps persist in assessing the severity of the coronavirus pandemic. Those gaps are worsened by a stressed global medical supply chain. The World’s Elana Gordon moderated a conversation with Dr. Michael Mina, assistant professor of epidemiology at Harvard T. H. Chan School of Public Health.
China has reported no new domestic cases of the novel coronavirus as the epicenter of the oubreak moves to Europe. US President Donald Trump is calling for a $1 trillion economic package, including $500 billion in direct payouts to Americans. And in Spain, reverberations from history: The legacy of former dictator, Gen. Fransisco Franco still lingers — even after being erased from the national record.
When will life get back to normal? Can our collective actions stop the global march of the virus? The World’s host Marco Werman posed those questions to Dr. Michael Mina, an infectious disease specialist at Harvard’s T.H. Chan School of Public Health.